Grufity logoGrufity logo

IVC

0.41USD-0.04(-8.83%)Market Closed

Invacare Corp

Market Summary

USD0.41-0.04Market Closed
-8.83%

IVC Stock Price

RSI Chart

Valuation

Market Cap

27.6M

Price/Earnings

-0.41

Price/Sales

0.03

Price/Cashflow

-5.31

MarketCap/EBT

-0.45

Price/Sales

Profitability

Operating Margin

26.10%

EBT Margin

-7.29%

Return on Equity

-45.37%

Return on Assets

-8.24%

Fundamentals

Revenue

Revenue (TTM)

786.6M

Revenue Y/Y

-23.99%

Revenue Q/Q

-9.85%

Earnings

Earnings (TTM)

-78.6M

Earnings Y/Y

-50.95%

Earnings Q/Q

-56.56%

Price Action

52 Week Range

0.333.23
(Low)(High)

Last 7 days

20.5%

Last 30 days

-43.8%

Last 90 days

-58.4%

Trailing 12 Months

-83.0%

Financial Health

Current Ratio

1.39

Debt/Equity

2.07

Debt/Cashflow

-0.02

Investor Care

Shares Dilution (1Y)

1.90%

Diluted EPS (TTM)

-2.18

Peers (Alternatives to Invacare)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-15.19% 31.17%
185.5K
28.0K
144.70% 331.94%
115.4B
30.8B
-8.94% -28.67%
22.17
3.71
-3.11% -8.14%
86.7B
17.9B
11.64% -6.61%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
11.18% -17.75%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
10.66% 2.81%
38.21
3.25
-6.81% -14.96%
43.9B
5.4B
5.44% -35.45%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
9.55% 2.62%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
33.31% -13.25%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-6.98% -2.00%
-29.57
10.69
18.85% -63.58%
3.6B
790.7M
14.84% -68.69%
-273.58
4.7
19.65% -412.22%
SMALL-CAP
1.6B
126.8M
23.76% 23.16%
-26.38
14.01
34.44% -10.05%
1.0B
795.9M
15.03% -14.89%
-131.34
1.33
8.11% 182.50%
994.0M
154.8M
3.15% -46.03%
-10.57
6.72
60.29% -2309.58%
606.7M
236.2M
-5.60% -30.91%
-16.43
2.57
-8.79% -175.19%

Financials for Invacare

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue-6.4%787840877872870
Cost Of Revenue-4.0%596621645633629
Gross Profit-13.2%190219232239241
  S&GA Expenses-0.3%228229234232240
  R&D Expenses-9
Earnings Before Taxes-20.4%-73.78-61.27-49.82-39.12-48.85
Net Income-17.3%-78.56-66.96-55.72-45.56-52.62
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-6.8%758813867910922
  Current Assets-7.0%295317350385377
    Cash Equivalents3.5%4544528474
  Inventory-13.1%121139147144151
  Net PPE-4.7%5356596162
  Goodwill-6.5%315337352356371
  Current Liabilities-2.2%223228233247230
  Long Term Debt-305----
    LT Debt, Current-0.5%22333
    LT Debt, Non Current6.9%333311309305306
Shareholder's Equity-45.1%81148189218240
  Retained Earnings-146.2%-57.85-23.49-1.552321
  Additional Paid-In Capital0.8%281279277277278
Shares Outstanding1.7%363535--
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-368.3%-24.36-5.20-28.25-14.31-15.73
  Share Based Compensation38.5%-1.20-1.96-1.2743
Cashflow From Investing37.0%-7.25-11.50-15.92-17.80-20.04
Cashflow From Financing190.8%10-11.49141322
  Dividend PaymentsNaN%00
  Buy Backs0%0022
* denotes actual numbers (not divided by Millions)

Risks

What is the probability of a big loss on IVC?

94.2%


Probability that Invacare stock will be more than 20% underwater in next one year

75.8%


Probability that Invacare stock will be more than 30% underwater in next one year.

71.9%


Probability that Invacare stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does IVC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Invacare was unfortunately bought at previous high price.

Returns

Cumulative Returns on IVC

-29.9%


10-Year Cumulative Returns

-42.0%


7-Year Cumulative Returns

-52.6%


5-Year Cumulative Returns

-64.5%


3-Year Cumulative Returns

What are the long-term rolling returns for IVC?

FIve years rolling returns for Invacare.

Which funds bought or sold IVC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-18
Pasadena Private Wealth, LLC
NEW
-
9,000
9,000
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-1,000
-
-%
2022-11-16
GLENMEDE TRUST CO NA
SOLD OFF
-100
-13,000
-
-%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
BNP PARIBAS ARBITRAGE, SNC
REDUCED
-94.5
-27,531
955
-%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
NOMURA HOLDINGS INC
REDUCED
-53.78
-1,084,000
458,000
-%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
ADDED
75.82
2,000
21,000
-%

1–10 of 37

Latest Funds Activity

Are funds buying IVC calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own IVC

Invacare News

Stocks Register

If You Don't Invest In Invacare Corporation (NYSE: IVC) Now, You'll Regret It Later..39 hours ago

Crain's Cleveland Business

IVC Fair Value

Recent SEC filings of Invacare

View All Filings
Date Filed Form Type Document
Nov 22, 2022
8-K/A
Current Report
Nov 22, 2022
SC 13D/A
13D - Major Acquisition
Nov 21, 2022
4
Insider Trading
Nov 21, 2022
4
Insider Trading
Nov 21, 2022
8-K
Current Report
Nov 16, 2022
4
Insider Trading
Nov 07, 2022
10-Q
Quarterly Report
Nov 07, 2022
8-K
Current Report
Oct 03, 2022
8-K
Current Report
Sep 29, 2022
8-K
Current Report

Latest Insider Trading transactions for IVC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-21
CRAWFORD EDWARD F
GIVEN BACK TO IS
-
-
-24,671
-
2022-11-21
Rosen Steven H
GIVEN BACK TO IS
-
-
-24,671
-
2022-11-18
Rosen Steven H
SOLD
-39,174.4
0.381
-102,820
-
2022-11-17
Rosen Steven H
SOLD
-9,060
0.453
-20,000
-
2022-11-16
Rosen Steven H
SOLD
-9,720
0.486
-20,000
-
2022-11-15
Rosen Steven H
SOLD
-38,700.4
0.496
-78,025
-
2022-11-14
Rosen Steven H
SOLD
-30,361
0.502
-60,480
-
2022-09-13
MERRIMAN MICHAEL J
ACQUIRED
-
-
154,852
-
2022-09-13
Purtill Geoffrey
ACQUIRED
-
-
100,000
President and CEO
2022-08-22
Rosen Steven H
ACQUIRED
-
-
24,671
-

1–10 of 50

Matthew E. Monaghan
3000
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.

IVC Income Statement

2022-09-30
Condensed Consolidated Statement of Comprehensive Income (Loss) - USD ($)
shares in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Statement of Comprehensive Income [Abstract]    
Net Sales$ 170,408,000$ 224,200,000$ 560,413,000$ 646,266,000
Cost of products sold139,029,000163,890,000433,323,000470,500,000
Gross Profit31,379,00060,310,000127,090,000175,766,000
Selling, general and administrative expenses55,365,00056,135,000174,552,000178,721,000
Charges related to restructuring activities8,440,000377,00016,383,0002,476,000
Impairment of Intangible Assets (Excluding Goodwill)1,012,00001,012,0000
Goodwill, Impairment Loss028,564,000028,564,000
Operating Loss(33,438,000)(24,766,000)(64,857,000)(33,995,000)
Net gain on convertible debt derivatives(950,000)0(950,000)0
Net gain on debt extinguishment(6,398,000)(10,131,000)(6,398,000)(9,422,000)
Interest expense7,354,0006,284,00019,836,00018,099,000
Interest Income, Other10,000011,0001,000
Loss Before Income Taxes(33,434,000)(20,919,000)(77,334,000)(42,671,000)
Income tax provision920,0001,840,0003,160,0004,830,000
Net Loss$ (34,354,000)$ (22,759,000)$ (80,494,000)$ (47,501,000)
Net Loss per Share—Basic    
Net Loss per Share—Basic$ (0.92)$ (0.65)$ (2.23)$ (1.36)
Weighted Average Shares Outstanding—Basic37,53735,01336,07334,826
Loss per Share—Assuming Dilution    
Loss per Share—Assuming Dilution[1]$ (0.92)$ (0.65)$ (2.23)$ (1.36)
Weighted Average Shares Outstanding—Assuming Dilution37,68035,48836,24135,371
Other comprehensive income (loss):    
Foreign currency translation adjustments$ (34,051,000)$ (19,202,000)$ (66,938,000)$ (6,487,000)
Defined Benefit Plans:    
Amortization of prior service costs and unrecognized losses45,000(27,000)4,608,000(422,000)
Deferred tax adjustment resulting from defined benefit plan activity(9,000)20,000(94,000)(43,000)
Valuation reserve associated with defined benefit plan activity9,000(20,000)94,00043,000
Current period gain (loss) on cash flow hedges(1,394,000)1,423,000298,000649,000
Deferred tax benefit (provision) related to gain on cash flow hedges178,000(170,000)(62,000)(73,000)
Other Comprehensive Loss(35,222,000)(17,976,000)(62,094,000)(6,333,000)
Comprehensive Loss$ (69,576,000)$ (40,735,000)$ (142,588,000)$ (53,834,000)
[1]Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.

IVC Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Dec. 31, 2020
Current Assets      
Cash and cash equivalents$ 45,439 $ 83,745   
Trade receivables, net80,105 117,115   
Installment receivables, net255 218   
Inventories, net120,687 144,274   
Other current assets48,338 40,036   
Total Current Assets294,824 385,388   
Other Assets5,330 5,362   
Intangibles, net23,390 26,356   
Property and Equipment, net53,244 60,921   
Finance Lease, Right-of-Use Asset56,083 63,029   
Operating Lease, Right-of-Use Asset9,980 12,600   
Goodwill314,755 355,875   
Total Assets757,606 909,531   
Current Liabilities      
Accounts payable95,973 130,036   
Accrued expenses116,330 102,971   
Current taxes payable2,136 3,914   
Current portion of long-term debt2,150 3,107   
Current portion of finance lease obligations3,031 3,009   
Current portion of operating lease obligations3,062 4,217   
Total Current Liabilities222,682 247,254   
Long-Term Debt333,129 305,022   
Finance Lease Long-Term Obligations57,511 63,736   
Operating Leases Long-Term Obligations6,865 8,234   
Other Long-Term Obligations56,374 66,796   
Shareholders’ Equity      
Preferred Shares (Authorized 300 shares; none outstanding)0 0   
Additional paid-in-capital281,130 276,665   
Retained earnings (accumulated deficit)(57,849) 22,645   
Accumulated other comprehensive income (loss)(45,106)$ (9,884)16,988$ 39,103$ 57,079$ 45,436
Treasury Shares (4,535 and 4,397 shares at September 30, 2022 and December 31, 2021, respectively)(107,939) (107,788)   
Total Shareholders’ Equity81,045$ 147,604218,489$ 239,714$ 280,890$ 333,846
Total Liabilities and Shareholders’ Equity757,606 909,531   
Common Shares [Member]      
Shareholders’ Equity      
Common Shares10,807 9,977   
Class B Common Shares [Member]      
Shareholders’ Equity      
Common Shares$ 2 $ 2